Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck

By              

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 175-177

Spandidos Publications

Access to resources Recommend Favorite

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

By Mortenson Melinda   Schlieman Michael   Virudachalam Subbulakshmi   Bold Richard  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 343-353

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

By Miyamoto Yuichiro   Nakagawa Shunsuke   Wada-Hiraike Osamu   Seiki Takayuki   Tanikawa Michihiro   Hiraike Haruko   Sone Kenbun   Nagasaka Kazunori   Oda Katsutoshi   Kawana Kei   Nakagawa Keiichi   Fujii Tomoyuki   Yano Tetsu   Kozuma Shiro   Taketani Yuji  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 51-57

Spandidos Publications

Access to resources Recommend Favorite

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells

By              

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1171-1176

Spandidos Publications

Access to resources Recommend Favorite